Clinical Trial Update: Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating oral vinorelbine with erlotinib in Non-Small Cell Lung Cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Navelbine (vinorelbine)
• Tarceva (erlotinib)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED